IRIS
MARCHETTI, Bianca Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.436
AS - Asia 3.267
EU - Europa 3.228
SA - Sud America 626
AF - Africa 293
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 14.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.127
SG - Singapore 1.746
RU - Federazione Russa 933
CN - Cina 856
IE - Irlanda 600
UA - Ucraina 597
BR - Brasile 528
IT - Italia 500
VN - Vietnam 245
CA - Canada 240
FR - Francia 173
SE - Svezia 107
CI - Costa d'Avorio 97
NG - Nigeria 83
KR - Corea 79
GB - Regno Unito 75
DE - Germania 67
IN - India 67
SN - Senegal 61
BD - Bangladesh 42
HK - Hong Kong 41
MX - Messico 38
AR - Argentina 36
PL - Polonia 31
IQ - Iraq 25
CH - Svizzera 19
ES - Italia 19
UZ - Uzbekistan 19
JP - Giappone 17
NL - Olanda 17
ID - Indonesia 15
PK - Pakistan 15
VE - Venezuela 15
EC - Ecuador 14
AT - Austria 13
CO - Colombia 12
EG - Egitto 12
FI - Finlandia 12
IR - Iran 12
ZA - Sudafrica 12
GR - Grecia 11
TR - Turchia 11
PY - Paraguay 10
LB - Libano 9
MA - Marocco 9
IL - Israele 7
JO - Giordania 7
LT - Lituania 7
NP - Nepal 7
BE - Belgio 6
EU - Europa 6
PH - Filippine 6
PT - Portogallo 6
JM - Giamaica 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
CZ - Repubblica Ceca 4
GT - Guatemala 4
KE - Kenya 4
KZ - Kazakistan 4
TH - Thailandia 4
AU - Australia 3
BO - Bolivia 3
BS - Bahamas 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
SA - Arabia Saudita 3
TN - Tunisia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CY - Cipro 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BG - Bulgaria 1
BJ - Benin 1
CD - Congo 1
Totale 14.850
Salva come PNG Salva come JPEG
Città #
Dallas 1.025
Singapore 971
Santa Clara 853
Jacksonville 722
Dublin 595
Chandler 545
San Jose 529
Houston 409
Moscow 351
Boardman 265
Ashburn 240
Lawrence 169
Nanjing 169
Cambridge 168
Chicago 168
Toronto 168
Andover 165
Lauterbourg 150
Catania 137
Beijing 111
Los Angeles 111
Des Moines 107
Abidjan 97
San Mateo 89
Ho Chi Minh City 82
Wilmington 80
Seoul 79
Hefei 72
Nanchang 62
Dakar 61
Council Bluffs 59
Hanoi 56
Abuja 53
Shenyang 53
Ottawa 47
New York 46
Civitanova Marche 45
Hebei 44
São Paulo 42
Hong Kong 36
Falls Church 33
Saint Petersburg 32
Tianjin 31
The Dalles 30
Changsha 28
Jiaxing 27
Orem 27
Buffalo 24
Columbus 24
Lagos 24
Rome 23
Seattle 21
Warsaw 18
Brooklyn 16
Grafing 16
Jinan 16
London 16
Tokyo 16
Belo Horizonte 15
San Francisco 15
Aversa 14
Messina 14
Milan 14
Norwalk 14
Pune 14
Leawood 13
Stockholm 13
Augusta 12
Tappahannock 12
Ardabil 11
Baghdad 11
Denver 11
Rio de Janeiro 11
Tashkent 11
Chennai 10
Kunming 10
Liberty Lake 10
Montreal 10
Da Nang 9
Johannesburg 9
Mascalucia 9
Mexico City 9
Porto Alegre 9
Ragusa 9
Washington 9
Ann Arbor 8
Curitiba 8
Dhaka 8
Frankfurt Am Main 8
Frankfurt am Main 8
Goiânia 8
Mumbai 8
Atlanta 7
Boston 7
Brasília 7
Fortaleza 7
Haiphong 7
Hangzhou 7
Lahore 7
Phoenix 7
Totale 10.073
Salva come PNG Salva come JPEG
Nome #
microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches 499
Small Extracellular Vesicles Secreted by Nigrostriatal Astrocytes Rescue Cell Death and Preserve Mitochondrial Function in Parkinson's Disease 212
Activation of cytosolic phospholipase A2 and 15-lipoxygenase by oxidized low-density lipoproteins in cultured human lung fibroblasts 183
Activation of phospholipase A2 and MAP kinases by oxidized low density lipoproteins in immortalized GP8.39 endothelial cells 163
High-resolution respirometry reveals mpp+ mitochondrial toxicity mechanism in a cellular model of parkinson’s disease 161
Extracellular vesicles as nanotherapeutics for Parkinson’s disease 156
A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus Gland function 151
A Wnt1 regulated Frizzled-1/beta-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection 149
Astrocytes from distinct nigrostriatal brain regions secrete extracellular vesicles able to mediate neuroprotection in cellular models of Parkinson's disease 147
Proteomic profile of extracellular vesicles secreted by astrocytes using high resolution mass spectrometry 145
Glia-Derived Extracellular Vesicles in Parkinson's Disease 144
Aging of the reproductive-neuroimmune axis. A crucial role for the hypothalamic neuropeptide luteinizing hormone-releasing hormone 142
46. Ruolo dei fattori di crescita di origine astrogliale ed esogeni nella migrazione, crescita, differenziazione e controllo funzionale di neuroni ipotalamici immortalizzati LH-RH secernenti. 135
Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain 135
Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3/Akt/Wnt/β-catenin signaling dysregulation 131
Ultrastructural and molecular characterization of astrocyte-derived extracellular vesicles from nigrostriatal brain regions: implications for dopaminergic neuroprotection 128
Mastering the Tools: Natural versus Artificial Vesicles in Nanomedicine 128
Extracellular vesicles as novel diagnostic and prognostic biomarkers for Parkinson’s disease 126
Vulnerability to Parkinson's Disease: Towards an Unifying Theory of Disease Etiology 121
Basic fibroblast growth factor priming increases the responsiveness of immortalized hypothalamic luteinizing hormone releasing hormone neurones to neurotrophic factors 119
MAPKs mediate activation of cytosolic phospholipase A2 by amyloid β(25-35) peptide in bovine retina pericytes 119
Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture 117
Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase. 117
Apoptotic cell death and amyloid precursor protein signaling in neuroblastoma SH-SY5Y cells. 116
BASIC FIBROBLAST GROWTH FACTOR (bFGF) PRIMING INCREASES THE RESPONSIVENESS OF IMMORTALIZED HYPOTHALAMIC LHRH NEURONS TO NEUROTROPHIC FACTORS 114
Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses. 112
BETA-ADRENERGIC RECEPTORS IN DIMETHYLBENZ(A)ANTHRACENE (DMBA)-INDUCED MAMMARY-TUMORS IN THE RAT AND THEIR MODULATION BY ESTROGENS 110
Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. 109
Acute brain ischemia and inflammation: an outcome study 109
Regulating Wnt signalling, a strategy to prevent neurodegeneration and induce regeneration 107
Brain endothelial cell-retinal pericyte co-cultures induce cytosolic phospholipase A2 protein expression through activation of PKCa and d isoforms and MAPK/ERK cascade 106
ADRENAL-STEROIDS STIMULATE GROWTH AND PROGESTERONE-RECEPTOR LEVELS IN RAT UTERUS AND DMBA-INDUCED MAMMARY-TUMORS 105
Beta-adrenergic receptors in DMBA-induced rat mammary tumors: correlation with progesterone receptor and tumor growth. 105
Phosphatidylserine counteracts physiological and pharmacological suppression of humoral immune response. 104
Cross-talk communication in the neuroendocrine-reproductive-immune axis. Age-dependent alterations in the common communication networks. 102
Cross-talk signals in the CNS: role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH)-astroglial interactive network. 101
Involvement of CD45 in dexamethasone- and heat shock-induced apoptosis of rat thymocytes. 100
Neuroendocrineimmunology (NEI) at the turn of the century: towards a molecular understanding of basic mechanisms and implications for reproductive physiopathology 99
Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis 99
Peptidergic modulation of immune system development: role of luteinizing hormone-releasing hormone. 98
A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of beta-adrenergic receptors and correlation with tumor growth. 96
Luteinizing hormone-releasing hormone is a primary signaling molecule in the neuroimmune network 96
Upregulation of lymphocyte beta-adrenergic receptor in Down's syndrome: a biological marker of a neuroimmune deficit 94
Opposite changes of pituitary and ovarian receptors for LHRH in ageing rats: further evidence for a direct neural control of ovarian LHRH receptor activity 94
Modulation of glucocorticoid receptor gene expression in the thymus by the sex steroid hormone milieu and correlation with sexual dimorphism of immune response 94
Effect of 17-beta estradiol and epidermal growth factor on DNA and RNA labeling in astroglial cells during development, maturation and differentiation in culture 94
The MPTP mouse model: Cues on DA release and neural stem cell restorative role 93
Partial blockade of T-cell differentiation during ontogeny and marked alterations of the thymic microenvironment in transgenic mice with impaired glucocorticoid receptor function 93
“Reframing” dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications 93
Inflammatory biomarkers in blood of patients with acute brain ischemia 92
Modulation of hippocampal LHRH receptors by sex steroids in the rat. 91
Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. 91
Chemokine-driven molecular cascade orchestrates injury and repair in the MPTP mouse model of basal ganglia injury: The chief instructive role of Writ and concerted glia-neuron cross-talk 91
Ovarian adrenergic nerves directly participate in the control of luteinizing hormone-releasing hormone and beta-adrenergic receptors during puberty: a biochemical and autoradiographic study. 91
A Double-Blind Trial with Naltrexone in Autism 90
Specificity of the direct effect of an LHRH agonist on testicular 17-hydroxylase but not on 5 alpha-reductase activity in hypophysectomized adult rats. 89
Signalling pathways in the nitric oxide and iron-induced dopamine release in the striatum of freely moving rats: role of extracellular Ca2+ and L-type Ca2+ channels 89
GLUCOCORTICOID-CYTOKINE INTERACTIONS - TYPE-II GLUCOCORTICOID RECEPTOR GENE-EXPRESSION IN THE THYMUS IS DOWN-REGULATED BY IMMUNE-SYSTEM ACTIVATION 89
Chitotriosidase in patients with acute ischemic stroke 88
I fattori di crescita EGF, IGF-I ed insulina stimolano la sintesi del DNA nelle colture astrogliali e neuronali pretrattate con bFGF. 86
Neuroinfiammazione, NOS inducibile e glucocorticoidi nella programmazione della vulnerabilità al danno neurodegenerativo 86
Luteinizing hormone- releasing hormone-binding sites in the rat thymus : characteristics and biological function 86
The LHRH-astroglial network of signals as a model to study neuroimmune interactions: assessment of messenger systems and transduction mechanisms at cellular and molecular levels. 86
Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. 85
Lutheinizing hormone-realeasing hormone (LH-RH) agonist restoration of age associated decline of thymus weight, thymic LH-RH receptors, and thymocyte proliferative capacity 85
Effect of EGF, IGF-I and insulin on protein labeling in bFGF pretreated or unpretreated nerve cell cultures during LHRH neuron-astrocyte interactions. 85
Exposure to a dysfunctional GR from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via NO-induced immunosuppression. J. Immunology 84
Impact of gender on longevity?: Estrogens modulation of neuroendocrine-immune axis and their possible role in aging pathologies 84
Wnt your brain be inflamed? Yes, it Wnt! 84
Glia as a Turning Point in the Therapeutic Strategy of Parkinson's Disease 84
Glucorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide 84
Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. 84
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington’s disease: involvement of astrocyte–neuron interactions 84
Immortalized hypothalamic luteinizing hormone-releasing hormone (LHRH) neurons induce a functional switch in the growth factor responsiveness of astroglia: involvement of basic fibroblast growth factor 84
Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration 84
Unilateral ovariectomy-induced luteinizing hormone-releasing hormone content changes in the two halves of the mediobasal hypothalamus. 83
Norepinephrinergic involvement in the neuronal mechanism regulating compensatory ovarian hypertrophy. 83
The thymus gland as a major target for the central nervous system and the neuroendocrine system: Neuroendocrine modulation of thymic beta(2)-Adrenergic receptor distribution as revealed by in vitro autoradiography. 82
THE NEUROENDOCRINE-IMMUNE CONNECTIONS IN THE CONTROL OF REPRODUCTIVE FUNCTIONS 82
Neural mechanisms in gonadal and adrenal hyperhophy. 82
BLOCKADE OF CENTRAL AND PERIPHERAL LUTHEINIZING HORMONE- RELEASING HORMONE (LH-RH) RECEPTORS IN NEONATOL RATS WITH A PATENT LH-RH ANTAGONIST INHIBITS THE MORFOFUNCTIONAL DEVELOPMENT OF THE THYMUS AND MATURATION OF THE CELL-MEDIATED AND HUMORAL IMMUNE RESPONSES 81
Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration. 81
Steroid hormone modulation of glial inducible nitric oxide synthase orchestrate neuroprotection in experimental parkinsonisin 81
Brain dysfunction and the immune system: lymphocyte's beta-adrenergic receptor in Down syndrome. 80
Multiple sclerosis and anti-Plasmodium falciparum innate immune response 80
The immune response evokes up- and down-modulation of beta 2-adrenergic receptor messenger RNA concentration in the male rat thymus. 79
Effetti di fattori di crescita endogeni rilasciati dai medium condizionati astrogliali sulla sintesi del DNA in colture di astrociti pretrattate con fattori di crescita esogeni 79
Tossicità epatica 79
The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron-glial interactions 79
To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? 78
Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone 78
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 78
MPTP-reactive “in situ” inflammation as a key event in the molecular cascade linking nigrostriatal injury to repair 78
Gender, neuroendocrine-immune interactions and neuron-glial plasticity. Role of luteinizing hormone-releasing hormone (LHRH). 78
Prevention of compensatory ovarian hypertrophy by local treatment of the ovary with 6-OHDA. 77
Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease 77
Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental Parkinsonism: pivotal role for glia-neuron interactions 77
Changes in hippocampal LH-RH receptor density during maturation and aging in the rat. 76
Further characterization of the direct inhibitory effect of LHRH agonists at the testicular level in the rat. 76
Therapeutic perspectives in psychoneuroendocrinimmunology (PNEI): potential role of phosphatidylserine in neuroendocrine-immune communications. 76
Totale 10.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 0 0 40
2021/20221.276 160 172 1 30 198 31 189 48 118 2 35 292
2022/20231.868 176 46 27 134 197 353 14 328 503 12 43 35
2023/2024645 63 72 28 46 24 77 23 66 4 15 128 99
2024/20252.870 41 384 175 100 778 266 84 152 230 290 172 198
2025/20265.702 287 234 1.075 375 894 1.005 807 129 306 303 135 152
Totale 15.095